Toggle navigation
Home
Search
Services
Blog
Contact
About
Diabetic Macular Edema - Classification & Natural Course
Davis, Matthew D.
University of Wisconsin Madison, Madison, WI, United States
Search 116 grants from Matthew Davis
Search grants from University of Wisconsin Madison
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
LPS binding to TLR4 regulates hepatic stellate cell activation and fibrosis
System for Screening Blood Donors with Pcr-Based Assays
Oligomerization and Folding of Membrane Proteins
Geriatric Rehabilitation Prognostic Staging System
Immunology Research
Recently added grants:
A Multienzyme Metabolic Complex for Glucose Metabolism
Structural investigation of the gating and regulatory mechanism of voltage-gated Ca2+ channels
Intracellular Cholesterol Transport
Mechanisms of glucose signal transduction in yeast
Implementation Support for Prevention Program Delivery by College Peer Educators
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Small Research Grants (R03)
Project #
5R03EY010295-02
Application #
2164056
Study Section
Special Emphasis Panel (SRC (03))
Project Start
1993-09-30
Project End
1996-12-31
Budget Start
1994-09-30
Budget End
1996-12-31
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Institution
Name
University of Wisconsin Madison
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Related projects
NIH 1994
R03 EY
Diabetic Macular Edema - Classification & Natural Course
Davis, Matthew D. / University of Wisconsin Madison
NIH 1993
R03 EY
Diabetic Macular Edema - Classification & Natural Course
Davis, Matthew D. / University of Wisconsin Madison
Publications
Davis, M D; Fisher, M R; Gangnon, R E et al.
(1998)
Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18.
Invest Ophthalmol Vis Sci 39:233-52
Comments
Be the first to comment on Matthew Davis's grant